GDF2 c.178G>A ;(p.E60K)

Variant ID: 10-48416516-C-T

NM_016204.1(GDF2):c.178G>A;(p.E60K)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Bone Morphogenetic Protein-Based Therapeutic Approaches.

Cold Spring Harbor Perspectives In Biology
Lowery, Jonathan W JW; Rosen, Vicki V
Publication Date: 2018-04-02

Variant appearance in text: BMP-9: E60K
PubMed Link: 28389444
Variant Present in the following documents:
  • Main text
View BVdb publication page



A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future Perspectives.

Stem Cells International
Lowery, Jonathan W JW; Brookshire, Brice B; Rosen, Vicki V
Publication Date: 2016

Variant appearance in text: BMP9: E60K
PubMed Link: 27433166
Variant Present in the following documents:
  • Main text
  • SCI2016-7290686.pdf
View BVdb publication page



Identification of a key residue mediating bone morphogenetic protein (BMP)-6 resistance to noggin inhibition allows for engineered BMPs with superior agonist activity.

The Journal Of Biological Chemistry
Song, Kening K; Krause, Carola C; Shi, Songting S; Patterson, Marilyn M; Suto, Robert R; Grgurevic, Lovorka L; Vukicevic, Slobodan S; van Dinther, Maarten M; Falb, Dean D; Ten Dijke, Peter P; Alaoui-Ismaili, Moulay Hicham MH
Publication Date: 2010-04-16

Variant appearance in text: BMP-9: E60K
PubMed Link: 20048150
Variant Present in the following documents:
  • Main text
View BVdb publication page